miR‑195 promotes LPS‑mediated intestinal epithelial cell apoptosis via targeting SIRT1/eIF2a

Yuan,Ting; Zhang,Li; Yao,Shuo; Deng,Shuang‑Ya; Liu,Ji‑Qiang

doi:10.3892/ijmm.2019.4431

miR‑195 promotes LPS‑mediated intestinal epithelial cell apoptosis via targeting SIRT1/eIF2a

Authors:
- Ting Yuan
- Li Zhang
- Shuo Yao
- Shuang‑Ya Deng
- Ji‑Qiang Liu
View Affiliations

Affiliations: Department of Emergency Medicine and Difficult Diseases Institute, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410001, P.R. China, Department of Respiratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410001, P.R. China, Department of General Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410001, P.R. China
Published online on: December 18, 2019 https://doi.org/10.3892/ijmm.2019.4431
Pages: 510-518
Copyright: © Yuan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A microarray analysis of an animal model with experimental sepsis induced by caecal ligation and puncture revealed that the level of microRNA‑195 (miR‑195) was upregulated. However, to the best of our knowledge, the role of miR‑195 in sepsis remains unknown. The present study investigated the effect of miR‑195 on apoptosis in sepsis and investigated the underlying mechanism. The level of miR‑195 was measured in human intestinal epithelial cells following exposure to lipopolysaccharide (LPS). Cell viability and apoptosis were detected using Cell Counting kit‑8 and flow cytometry assays. The expression levels of apoptosis‑associated proteins were determined using western blot analysis. In addition, a dual‑luciferase reporter assay was employed to verify the association between miR‑195 and sirtuin 1 (SIRT1). Furthermore, the SIRT1 inhibitor EX527 was applied to further confirm the regulatory network of miR‑195/SIRT1 in LPS‑induced apoptosis. It was demonstrated that LPS significantly inhibited cell viability and promoted cell apoptosis in NCM460 cells in a dose‑dependent manner. In addition, miR‑195 was significantly upregulated following LPS treatment. The present results revealed that silencing miR‑195 prevented apoptosis and alleviated cell injury in LPS‑induced NCM460 cells. Further investigation demonstrated that miR‑195 bound directly to and negatively regulated SIRT1. Inhibition of SIRT1 reversed the protective effects of miR‑195‑silencing on the apoptosis and viability of NCM460 cells. Furthermore, silencing miR‑195 prevented endoplasmic reticulum (ER) stress‑induced apoptosis via a downregulation of SIRT1 and its downstream effectors, including activating transcription factor 4, C/EBP homologous protein, glucose‑regulated protein 78 and growth arrest and DNA‑damage protein 34, as well as the phosphorylation of eukaryotic translation initiation factor 2A. In conclusion, the present study revealed a novel mechanism by which miR‑195 regulates SIRT1‑mediated downstream effectors in ER stress‑induced apoptosis in sepsis.

View Figures

View References

1	Kaukonen KM, Bailey M, Pilcher D, Cooper DJ and Bellomo R: Systemic inflammatory response syndrome criteria in defining severe sepsis. New Engl J Med. 372:1629–1638. 2015. View Article : Google Scholar : PubMed/NCBI
2	Thimmulappa RK, Lee H, Rangasamy T, Reddy SP, Yamamoto M, Kensler TW and Biswal S: Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest. 116:984–995. 2006. View Article : Google Scholar : PubMed/NCBI
3	Fleischmann C, Thomas-Rueddel DO, Hartmann M, Hartog CS, Welte T, Heublein S, Dennler U and Reinhart K: Hospital incidence and mortality rates of sepsis. Dtsch Arztebl Int. 113:159–166. 2016.PubMed/NCBI
4	Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, et al: Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 45:486–552. 2017. View Article : Google Scholar : PubMed/NCBI
5	Hunter JG, Pritchett C, Pandya D, Cripps A and Langford R: Sim-sepsis: Improving sepsis treatment in the emergency department? BMJ Simul Technol Enhanc Learn. 2018:bmjstel2018.
6	Fay KT, Ford ML and Coopersmith CM: The intestinal micro-environment in sepsis. Biochim Biophysica Acta Mol Basis Dis. 1863:2574–2583. 2017. View Article : Google Scholar
7	Yoseph BP, Klingensmith NJ, Liang Z, Breed ER, Burd EM, Mittal R, Dominguez JA, Petrie B, Ford ML and Coopersmith CM: Mechanisms of intestinal barrier dysfunction in sepsis. Shock. 46:52–59. 2016. View Article : Google Scholar : PubMed/NCBI
8	Gill SE, Rohan M and Mehta S: Role of pulmonary microvascular endothelial cell apoptosis in murine sepsis-induced lung injury in vivo. Respir Res. 16:1–13. 2015. View Article : Google Scholar
9	Luan Y, Yao Y, Xiao X and Sheng Z: Insights into the apoptotic death of immune cells in sepsis. J Interferon Cytokine Res. 35:17–22. 2015. View Article : Google Scholar :
10	Delano MJ and Ward PA: Sepsis-induced immune dysfunction: Can immune therapies reduce mortality? J Clin Invest. 126:23–21. 2016. View Article : Google Scholar : PubMed/NCBI
11	Fang W and Bartel DP: The menu of features that define primary microRNAs and enable de novo design of microRNA genes. Mol Cell. 60:131–145. 2015. View Article : Google Scholar : PubMed/NCBI
12	Giza DE, Fuentesmattei E, Bullock MD, Tudor S, Goblirsch MJ, Fabbri M, Lupu F, Yeung SJ, Vasilescu C and Calin GA: Cellular and viral microRNAs in sepsis: Mechanisms of action and clinical applications. Cell Death Differ. 23:1906–1918. 2016. View Article : Google Scholar : PubMed/NCBI
13	Gao M, Wang X, Zhang X, Ha T, Ma H, Liu L, Kalbfleisch JH, Gao X, Kao RL and Williams DL: Attenuation of cardiac dysfunction in polymicrobial sepsis by MicroRNA-146a is mediated via targeting of IRAK1 and TRAF6 expression. J Immunol. 195:672–682. 2015. View Article : Google Scholar : PubMed/NCBI
14	Roderburg C, Luedde M, Vargas Cardenas DV, Vucur M, Scholten D, Frey N, Koch A, Trautwein C, Tacke F and Luedde T: Circulating MicroRNA-150 serum levels predict survival in patients with critical illness and sepsis. PLoS One. 8:e546122013. View Article : Google Scholar : PubMed/NCBI
15	Tacke F, Roderburg C, Benz F, Cardenas DV, Luedde M, Hippe HJ, Frey N, Vucur M, Gautheron J, Koch A, et al: Levels of circulating miR-133a are elevated in sepsis and predict mortality in critically ill patients. Crit Care Med. 42:1096–1104. 2014. View Article : Google Scholar : PubMed/NCBI
16	Wu J, Ji A, Wang X, Zhu Y, Yu Y, Lin Y, Liu Y, Li S, Liang Z, Xu X, et al: MicroRNA-195-5p a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells. J Transl Med. 13:2892015. View Article : Google Scholar
17	Almeida MI, Silva AM, Vasconcelos DM, Almeida CR, Caires H, Pinto MT, Calin GA, Santos SG and Barbosa MA: MiR-195 in human primary mesenchymal stromal/stem cells regulates proliferation, osteogenesis and paracrine effect on angiogenesis. Oncotarget. 7:7–22. 2016. View Article : Google Scholar :
18	Wu SC, Yang JC, Rau CS, Chen YC, Lu TH, Lin MW, Tzeng SL, Wu YC, Wu CJ and Hsieh CH: Profiling circulating MicroRNA expression in experimental sepsis using cecal ligation and puncture. PLoS One. 8:e779362013. View Article : Google Scholar : PubMed/NCBI
19	Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, et al: SIRT1 is required for AMPK activation and the beneficial effects of resve-ratrol on mitochondrial function. Cell Metab. 15:675–690. 2012. View Article : Google Scholar : PubMed/NCBI
20	Gao R, Ma Z, Hu Y, Chen J, Shetty S and Fu J: Sirt1 restrains lung inflammasome activation in a murine model of sepsis. Am J Physiol Lung Cell Mol Physiol. 308:L847–L853. 2015. View Article : Google Scholar : PubMed/NCBI
21	Li T, Zhang J, Feng J, Li Q, Wu L, Ye Q, Sun J, Lin Y, Zhang M, Huang R, et al: Resveratrol reduces acute lung injury in a LPS-induced sepsis mouse model via activation of Sirt1. Mol Med Rep. 7:1889–1895. 2013. View Article : Google Scholar : PubMed/NCBI
22	Opal S, Ellis JL, Suri V, Freudenberg JM, Vlasuk GP, Li Y, Chahin AB, Palardy JE, Parejo N, Yamamoto M, et al: Sirt1 activation markedly alters transcription profiles and improves outcome in experimental sepsis. Shock. 28:559–567. 2015.
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
24	Prola A, Pires Da Silva J, Guilbert A, Lecru L, Piquereau J, Ribeiro M, Mateo P, Gressette M, Fortin D, Boursier C, et al: SIRT1 protects the heart from ER stress-induced cell death through eIF2α deacetylation. Cell Death Differ. 24:343–356. 2017. View Article : Google Scholar
25	Djoumerska-Alexieva I, Pashova S, Vassilev T and Pashov A: The protective effect of modified intravenous immunoglobulin in LPS sepsis model is associated with an increased IRA B cells response. Autoimmun Rev. 12:653–656. 2013. View Article : Google Scholar
26	Paunel-Görgülü A, Flohé S, Scholz M, Windolf J and Lögters T: Increased serum soluble Fas after major trauma is associated with delayed neutrophil apoptosis and development of sepsis. Critical Care. 15:R202011. View Article : Google Scholar :
27	Cai B, Deitch EA and Ulloa L: Novel insights for systemic inflammation in sepsis and hemorrhage. Med Inflamm. 2010:6424622010. View Article : Google Scholar
28	Kingsley SMK and Bhat BV: Role of microRNAs in sepsis. Inflamm Res. 66:1–17. 2017. View Article : Google Scholar
29	Zheng D, Yu Y, Li M, Wang G, Chen R, Fan GC, Martin C, Xiong S and Peng T: Inhibition of MicroRNA 195 prevents apoptosis and multiple-organ injury in mouse models of sepsis. J Infect. 213:1661–1670. 2016. View Article : Google Scholar
30	Liu TF, Vachharajani V, Millet P, Bharadwaj MS, Molina AJ and Mccall CE: Sequential actions of SIRT1-RELB-SIRT3 coordinate nuclear-mitochondrial communication during immunometabolic adaptation to acute inflammation and sepsis. J Biol Chem. 290:396–408. 2015. View Article : Google Scholar :
31	Vachharajani VT, Liu T, Brown CM, Wang X, Buechler NL, Wells JD, Yoza BK and Mccall CE: SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome. J Leuk Biol. 96:785–796. 2014. View Article : Google Scholar
32	Zhou Q, Han LR, Zhou YX and Li Y: MiR-195 suppresses cervical cancer migration and invasion through targeting smad3. Int J Gynecol Cancer. 26:817–824. 2016. View Article : Google Scholar : PubMed/NCBI
33	Li B and Wang S and Wang S: MiR-195 suppresses colon cancer proliferation and metastasis by targeting WNT3A. Mol Genet Genomics. 293:1245–1253. 2018. View Article : Google Scholar : PubMed/NCBI
34	Zhu H, Yang Y, Wang Y, Li J, Schiller PW and Peng T: MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovasc Res. 92:75–84. 2011. View Article : Google Scholar : PubMed/NCBI
35	Liu Z, Gu H, Lu G, Xu Y, Fei F, Saeed M and Chao S: Reducing Smad3/ATF4 was essential for Sirt1 inhibiting ER stress-induced apoptosis in mice brown adipose tissue. Oncotarget. 8:9267–9279. 2016.PubMed/NCBI
36	Koga T, Suico MA, Shimasaki S, Watanabe E, Kai Y, Koyama K, Omachi K, Morino-Koga S, Sato T, Shuto T, et al: Endoplasmic reticulum (ER) stress induces sirtuin 1 (SIRT1) expression via the PI3K-Akt-GSK3β signaling pathway and promotes hepatocellular injury. J Biol Chem. 290:30366–30374. 2015. View Article : Google Scholar : PubMed/NCBI
37	Prola A, Silva JP, Guilbert A, Lecru L, Piquereau J, Ribeiro M, Mateo P, Gressette M, Fortin D, Boursier C, et al: SIRT1 protects the heart from ER stress-induced cell death through eIF2α deacetylation. Cell Death. 24:343–356. 2016. View Article : Google Scholar